Portfolio of high-complexity biologic and biosimilar medicines produced and distributed by Bionovis across five medical specialties.

Bionovis
Bionovis is a Brazilian biotechnology company producing biologic medicines and biosimilars.
Bionovis researches, develops, manufactures, and commercializes high-complexity biopharmaceuticals and biosimilars. The company is certified by the Brazilian health regulator ANVISA to produce biologic medicines and has sold more than 19 million medicines across Brazil.
It partners with global pharmaceutical companies and public laboratories to bring biologic production technology into the country. Its industrial plant operates mammalian cell-culture lines using perfusion and fed-batch processes with total reactor volume above 20,000 liters.
Products & Services
Similar Companies

Cristália
cristalia.com.br

Biocon
biocon.com
Samsung Bioepis
samsungbioepis.com

Sandoz
sandoz.com

Fresenius Kabi
fresenius-kabi.com

Libbs Farmaceutica
libbs.com.br

Boehringer Ingelheim

WuXi Biologics
wuxibiologics.com

Biolab
biolabeco.com.br

Celltrion
celltrion.com

Microbiológica

Bigens
bigens.com.br

Novozymes
novozymes.com
Amgen
amgen.com

Polpharma Biologics
Quick Facts
Who are Bionovis' competitors?
Companies similar to Bionovis include Cristália, Biocon, Samsung Bioepis and Sandoz.
When was Bionovis founded?
Bionovis was founded in 2012.
Where is Bionovis' headquarters located?
Bionovis' headquarters is located in Valinhos, Sp, BR.
When was Bionovis' last funding round?
Bionovis' most recent funding round was for R$650M (BRL) in January 2025.
How much disclosed funding has Bionovis raised?
As of Jan 17, 2025, Bionovis has disclosed funding of R$851M (BRL). Undisclosed round amounts are excluded.
Classification
- Industry
- Tags

